Magnetic resonance in surgical oncology: I - On the origin of the spectrum

ANZ Journal of Surgery

Volumn 75, Issue 6, 2005, Pages 459-463

  Gluch, Laurence ^a,b  

^a ANZAC Research Institute   (Australia)

^b Strathfield Breast Centre   (Australia)

Author keywords

Magnetic resonance spectroscopy; Surgical oncology

Indexed keywords

CANCER DIAGNOSIS; CANCER SURGERY; CELL METABOLISM; CELL STRUCTURE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; EVIDENCE BASED MEDICINE; HISTORY OF MEDICINE; IN VITRO STUDY; IN VIVO STUDY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSICS; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; TUMOR DIFFERENTIATION;

HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASMS;

EID: 21244478242     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2005.03385.x     Document Type: Review

References (50)

1. Little M. 'Better than numbers . . .' A gentle critique of evidence-based medicine. ANZ J. Surg. 2003; 73: 177-82.
2. Malycha P. Sentinel lymph node biopsy. ANZ J. Surg. 2003; 73: 370-1.
3. Rabi II, Zacharias JR, Millman S, Kusch P. A new method measuring nuclear magnetic moment. Phys. Rev. 1938; 53: 318.
4. Ramsey NF. Early history of magnetic resonance. Phys. Perspect. 1999; 1: 123-35.
5. Becker ED. A brief history of nuclear magnetic resonance. Anal. Chem. 1993; 65: 295A-302A.
6. Bloch F, Hansen WW, Packard M. The nuclear induction experiment. Phys. Rev. 1946; 70: 474-85.
7. Purcell EM, Torrey HC, Pound RV. Resonance absorption by nuclear magnetic moments in a solid. Phys. Rev. 1946; 69: 37-8.
8. Gutowsky HS, McCall DW. Nuclear magnetic resonance fine structure in liquids. Phys. Rev. 1951; 82: 748-9.
9. Ramsey NF, Purcell EM. Interaction between nuclear spins in molecules. Phys. Rev. 1952; 85: 143-4.
10. Hahn EL. An accurate nuclear magnetic resonance method for measuring spin-lattice relaxation times. Phys. Rev. 1949; 76: 145-6.
11. Hahn EL. Spin echoes. Phys. Rev. 1950; 80: 580-94.
12. Lowe IJ, Norberg RE. Free induction decays in solids. Phys. Rev. 1957; 107: 46-61.
13. Ernst RR, Anderson WA. Application of Fourier transform spectroscopy to magnetic resonance. Rev. Sci. Instrum. 1966; 37: 93-102.
14. Arnold JT, Dharmatti SS, Packard MM. Chemical effects on nuclear induction signals from organic compounds. Chem. Phys. 1951; 19: 507.
15. Saunders M, Wishnia A, Kirkwood JG. The NMR spectrum of ribonuclease. J. Am. Chem. Soc. 1957; 79: 3289-90.
16. Jardetsky O, Jardetsky CD. An interpretation of the proton nuclear magnetic resonance spectrum of ribonuclease. J. Am. Chem. Soc. 1957; 79: 5322-3.
17. Bovey FA. Nuclear Magnetic Spectroscopy. New York: Academic Press, 1968.
18. McDonald CC, Phillips WD. Manifestations of the tertiary structures of proteins in high frequency nuclear magnetic resonance. J. Am. Chem. Soc. 1967; 89: 6332-41.
19. Alger JR. The 1991 Nobel prize in chemistry awarded to an MRI investigator. J. Comput. Assist. Tomogr. 1992; 16: 1-2.
20. Aue WP, Bartholdi E, Ernst RR. Two-dimensional spectroscopy. Application to nuclear magnetic resonance. J. Chem. Phys. 1976; 64: 2229-46.
21. 1H nuclear magnetic resonance and distance geometry. J. Mol. Biol. 1985; 182: 295-315.
22. Damadian R. Tumor detection by nuclear magnetic resonance. Science 1971; 171: 1151-3.
23. 31P magnetic resonance. J. Biol. Chem. 1973; 248: 7276-8.
24. 31P NMR examination of two patients with NADH-CoQ reductase deficiency. Nature 1982; 295: 608-9.
25. Shulman RG. High resolution NMR in vivo. Trends Biochem. Sci. 1988; 13: 37-9.
26. Lautebur PC. Image formation by induced local interactions: Examples employing nuclear magnetic resonance. Nature 1973; 243: 190-4.
27. Mansfield P, Maudsley AA. Line scan proton spin imaging in biological structures by NMR. Phys. Med. Biol. 1976; 21: 847-52.
28. Mansfield P, Maudsley AA. Medical imaging by NMR. Br. J. Radiol. 1977; 50: 188-94.
29. Pykett IL, Mansfield P. A line scan image study of a tumorous rat leg by NMR. Phys. Med. Biol. 1978; 23: 961-7.
30. Mansfield P, Pykett IL, Morris PG. Human whole body line-scan imaging by NMR. Br. J. Radiol. 1978; 51: 921-2.
31. Smith ICP, Bezabeh T. Tissue NMR Ex Vivo. In: Young IR (ed.) Methods in Biomedical Magnetic Resonance Imaging and Spectroscopy, Vol. 2. Chichester: John Wiley and Sons, 2000; 891-8.
32. Smith ICP, Blandford DE. Magnetic resonance in medicine, high resolution ex-vivo. In: Meyers RA (ed.) Encyclopedia of Analytical Chemistry. Chichester: John Wiley and Sons, 2000; 188-201.
33. Smith ICP, Stewart LC. Magnetic resonance spectroscopy in medicine: Clinical impact. Prog. Nucl. Mag. Res. Sp. 2002; 40: 1-34.
34. Mountford CE, Grossman G, Gatenby PA, Fox RM. High-resolution proton nuclear magnetic resonance: Application to the study of leukaemic lymphocytes. Br. J. Cancer 1980; 41: 1000-3.
35. Mountford CE, Mackinnon WB, Bloom M, Burnell EE, Smith IC. NMR methods for characterizing the state of the surfaces of complex mammalian cells. J. Biochem. Biophys. Methods 1984; 9: 323-30.
36. Holmes KT, Williams PG, May GL et al. Cell surface involvement in cancer metastasis: An NMR study. FEBS Lett. 1986; 202: 122-6.
37. Wright LC, May GL, Gregory P et al. Inhibition of metastatic potential by fucosidase: An NMR study identifies a cell surface metastasis marker. J. Cell. Biochem. 1988; 37: 49-59.
38. Mountford CE, Lean CL, Hancock R et al. Magnetic resonance spectroscopy detects cancer in draining lymph nodes. Invas. Metast. 1993; 13: 57-71.
39. Lichtor T, Dohrmann GJ. Respiratory patterns in human brain tumors. Neurosurgery 1986; 19: 896-9.
40. Warburg O. On the origin of cancer cells. Science 1956; 123: 309.
41. Kaplan O, Cohen JS. Metabolism of breast cancer cells as revealed by non-invasive magnetic resonance spectroscopy studies. Breast Cancer Res. Treat. 1994; 31: 285-99.
42. Nakamura K, Kituta T, Takahashi T, Nakamura Y, Nakajima Y. A new cancer marker: A possible cancer screening method based on the suppression of phosphofructokinase by sera from cancer patients. Cancer Detect. Prev. 1985; 8: 207-18.
43. Mountford CE, Tattersall MH. Proton magnetic resonance spectroscopy and tumour detection. Cancer Surv. 1987; 6: 285-314.
44. Chajes V, Lanson M, Fetissof F, Lhuillery C, Bougnoux P. Membrane fatty acids of breast carcinoma: Contribution of host fatty acids and tumor properties. Int. J. Cancer 1995; 63: 169-75.
45. May GL, Wright LC, Lean CL, Mountford CE. Identification of 1-O-alkyl-2,3-diacyl-sn-glycerol in plasma membranes of cancer cells. J. Magn. Reson. Imaging 1992; 98: 622-7.
46. 1H MRS. Magn. Reson. Med. 1990; 13: 324-31.
47. Czuba M, Smith IC. Biological and NMR markers for cancer. Pharmacol. Ther. 1991; 50: 147-90.
48. Le Moyec L, Tatoud R, Eugene M et al. Cell and membrane lipid analysis by proton magnetic resonance spectroscopy in five breast cancer cell lines. Br. J. Cancer 1992; 66: 623-8.
49. Lanson M, Bougnoux P, Besson P et al. N-6 polyunsaturated fatty acids in human breast carcinoma phosphatidylethanolamine and early relapse. Br. J. Cancer 1990; 61: 776-8.
50. Hakomori S. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv. Cancer Res. 1989; 52: 257-331.